HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children.

Abstract
Fifty-five children with cholestatic cirrhosis due to extrahepatic biliary atresia received a course of hepatitis B vaccine. Forty-seven received a plasma-derived vaccine and eight a recombinant vaccine. Antibody determination was evaluated before and after liver transplantation in 30 patients. Twenty-five additional patients had antibody determination after transplantation only. Protection against hepatitis B was observed in 73.3% of the children evaluated prior to transplantation. One to 15 months after transplantation, 54.6% of all children studied showed protective levels of anti HBs. We conclude that hepatitis B vaccination is efficient in inducing immunity in the majority of children with cholestatic cirrhosis. Some patients will loose immunity under immunosuppression, but the protection rate remains higher than reported for patients vaccinated after transplantation.
AuthorsE M Sokal, L Ulla, J B Otte
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 37 Issue 8 Pg. 1250-2 (Aug 1992) ISSN: 0163-2116 [Print] United States
PMID1499450 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Hepatitis B Antibodies
  • Viral Hepatitis Vaccines
Topics
  • Biliary Atresia (complications, epidemiology, immunology, surgery)
  • Child
  • Child, Preschool
  • Hepatitis B (prevention & control)
  • Hepatitis B Antibodies (blood)
  • Humans
  • Immunization
  • Infant
  • Liver Cirrhosis, Biliary (epidemiology, etiology, immunology, surgery)
  • Liver Transplantation (immunology, statistics & numerical data)
  • Retrospective Studies
  • Time Factors
  • Viral Hepatitis Vaccines (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: